Biothera Receives 2009 Frost & Sullivan Excellence in Research Award

Biothera today received the 2009 Frost & Sullivan Excellence in Research Award for the development of Wellmune WGP(R), a natural food, beverage and supplement ingredient that, according to Frost & Sullivan analyst Sneha Pasricha, is "now considered a benchmark in the market for immune health ingredients."

Wellmune WGP is clinically proven to enhance key immune cells, which are the body's first line of defense, to fight foreign challenges. Years of research demonstrate that immune system enhancement with Wellmune WGP has a positive effect on overall health and protects against the effects of stress on physical and psychological well-being. Wellmune WGP, which is derived from proprietary yeast, is patented, GRAS, TGA-approved, Kosher, Halal, non-allergenic and GMO-free. The ingredient received the 2007 Innovation Award from the Institute of Food Technologists (IFT).

"We are pleased to receive the Frost & Sullivan award, which recognizes Biothera's dedication and commitment to rigorous scientific research on the real health benefits of Wellmune WGP," said Richard Mueller, chief executive officer of Biothera. "Biothera is redefining the immune health category with completely natural products that are backed by credible science and that do not over stimulate the immune system."

According to Pasricha: "Biothera's Wellmune WGP(R) is one of the most evidence-based, natural food and beverage ingredients in the industry, that activates key immune cells including macrophages and neutrophils and protects against stress-induced health challenges. This has been validated by numerous scientific/clinical studies conducted at the world's leading universities and research institutions, and has been widely published in peer-reviewed medical journals."

About the Frost & Sullivan Award Frost & Sullivan's Excellence in Research of the Year Award is bestowed upon a company that has carried out new "disruptive" research, and has, in general, a strong commitment to research and development. This award recognizes a company's research and development program that has or is expected to bring significant contributions to the industry in terms of adoption, change, and competitive posture. The fruits of this research may already have or will potentially impact certain market sectors. The award also recognizes the company's overall research excellence as well as its commitment toward differentiating itself based on science-backed services or solutions.

About Frost & Sullivan Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit

About Biothera, the Immune Health Company Biothera is a biotechnology company dedicated to developing novel ingredients that improve immune health. We manufacture and market patented, GRAS ingredients for functional foods and beverages, nutritional supplements, cosmetics and animal nutrition products worldwide. Wellmune WGP(R) and our other novel gluco polysaccharide ingredients are clinically proven to enhance the immune system and protect against a wide range of challenges. Biothera was founded in 1997 and is based in Eagan, Minnesota, USA. Visit our website at

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.